Chapter/Section Purchase

1 Study Coverage
1.1 Gabapentin Enacarbil Product Introduction
1.2 Market by Type
1.2.1 Global Gabapentin Enacarbil Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsule
1.2.3 Tablet
1.3 Market by Application
1.3.1 Global Gabapentin Enacarbil Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Post-Herpetic Neuralgia (PHN)
1.3.3 Restless Legs Syndrome (RLS)
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gabapentin Enacarbil Sales Estimates and Forecasts 2017-2028
2.2 Global Gabapentin Enacarbil Revenue Estimates and Forecasts 2017-2028
2.3 Global Gabapentin Enacarbil Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Gabapentin Enacarbil Sales by Region
2.4.1 Global Gabapentin Enacarbil Sales by Region (2017-2022)
2.4.2 Global Sales Gabapentin Enacarbil by Region (2023-2028)
2.5 Global Gabapentin Enacarbil Revenue by Region
2.5.1 Global Gabapentin Enacarbil Revenue by Region (2017-2022)
2.5.2 Global Gabapentin Enacarbil Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Gabapentin Enacarbil Sales by Manufacturers
3.1.1 Global Top Gabapentin Enacarbil Manufacturers by Sales (2017-2022)
3.1.2 Global Gabapentin Enacarbil Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gabapentin Enacarbil in 2021
3.2 Global Gabapentin Enacarbil Revenue by Manufacturers
3.2.1 Global Gabapentin Enacarbil Revenue by Manufacturers (2017-2022)
3.2.2 Global Gabapentin Enacarbil Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Gabapentin Enacarbil Revenue in 2021
3.3 Global Gabapentin Enacarbil Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gabapentin Enacarbil Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gabapentin Enacarbil Sales by Type
4.1.1 Global Gabapentin Enacarbil Historical Sales by Type (2017-2022)
4.1.2 Global Gabapentin Enacarbil Forecasted Sales by Type (2023-2028)
4.1.3 Global Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
4.2 Global Gabapentin Enacarbil Revenue by Type
4.2.1 Global Gabapentin Enacarbil Historical Revenue by Type (2017-2022)
4.2.2 Global Gabapentin Enacarbil Forecasted Revenue by Type (2023-2028)
4.2.3 Global Gabapentin Enacarbil Revenue Market Share by Type (2017-2028)
4.3 Global Gabapentin Enacarbil Price by Type
4.3.1 Global Gabapentin Enacarbil Price by Type (2017-2022)
4.3.2 Global Gabapentin Enacarbil Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Gabapentin Enacarbil Sales by Application
5.1.1 Global Gabapentin Enacarbil Historical Sales by Application (2017-2022)
5.1.2 Global Gabapentin Enacarbil Forecasted Sales by Application (2023-2028)
5.1.3 Global Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
5.2 Global Gabapentin Enacarbil Revenue by Application
5.2.1 Global Gabapentin Enacarbil Historical Revenue by Application (2017-2022)
5.2.2 Global Gabapentin Enacarbil Forecasted Revenue by Application (2023-2028)
5.2.3 Global Gabapentin Enacarbil Revenue Market Share by Application (2017-2028)
5.3 Global Gabapentin Enacarbil Price by Application
5.3.1 Global Gabapentin Enacarbil Price by Application (2017-2022)
5.3.2 Global Gabapentin Enacarbil Price Forecast by Application (2023-2028)
6 North America
6.1 North America Gabapentin Enacarbil Market Size by Type
6.1.1 North America Gabapentin Enacarbil Sales by Type (2017-2028)
6.1.2 North America Gabapentin Enacarbil Revenue by Type (2017-2028)
6.2 North America Gabapentin Enacarbil Market Size by Application
6.2.1 North America Gabapentin Enacarbil Sales by Application (2017-2028)
6.2.2 North America Gabapentin Enacarbil Revenue by Application (2017-2028)
6.3 North America Gabapentin Enacarbil Market Size by Country
6.3.1 North America Gabapentin Enacarbil Sales by Country (2017-2028)
6.3.2 North America Gabapentin Enacarbil Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Gabapentin Enacarbil Market Size by Type
7.1.1 Europe Gabapentin Enacarbil Sales by Type (2017-2028)
7.1.2 Europe Gabapentin Enacarbil Revenue by Type (2017-2028)
7.2 Europe Gabapentin Enacarbil Market Size by Application
7.2.1 Europe Gabapentin Enacarbil Sales by Application (2017-2028)
7.2.2 Europe Gabapentin Enacarbil Revenue by Application (2017-2028)
7.3 Europe Gabapentin Enacarbil Market Size by Country
7.3.1 Europe Gabapentin Enacarbil Sales by Country (2017-2028)
7.3.2 Europe Gabapentin Enacarbil Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gabapentin Enacarbil Market Size by Type
8.1.1 Asia Pacific Gabapentin Enacarbil Sales by Type (2017-2028)
8.1.2 Asia Pacific Gabapentin Enacarbil Revenue by Type (2017-2028)
8.2 Asia Pacific Gabapentin Enacarbil Market Size by Application
8.2.1 Asia Pacific Gabapentin Enacarbil Sales by Application (2017-2028)
8.2.2 Asia Pacific Gabapentin Enacarbil Revenue by Application (2017-2028)
8.3 Asia Pacific Gabapentin Enacarbil Market Size by Region
8.3.1 Asia Pacific Gabapentin Enacarbil Sales by Region (2017-2028)
8.3.2 Asia Pacific Gabapentin Enacarbil Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Gabapentin Enacarbil Market Size by Type
9.1.1 Latin America Gabapentin Enacarbil Sales by Type (2017-2028)
9.1.2 Latin America Gabapentin Enacarbil Revenue by Type (2017-2028)
9.2 Latin America Gabapentin Enacarbil Market Size by Application
9.2.1 Latin America Gabapentin Enacarbil Sales by Application (2017-2028)
9.2.2 Latin America Gabapentin Enacarbil Revenue by Application (2017-2028)
9.3 Latin America Gabapentin Enacarbil Market Size by Country
9.3.1 Latin America Gabapentin Enacarbil Sales by Country (2017-2028)
9.3.2 Latin America Gabapentin Enacarbil Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gabapentin Enacarbil Market Size by Type
10.1.1 Middle East and Africa Gabapentin Enacarbil Sales by Type (2017-2028)
10.1.2 Middle East and Africa Gabapentin Enacarbil Revenue by Type (2017-2028)
10.2 Middle East and Africa Gabapentin Enacarbil Market Size by Application
10.2.1 Middle East and Africa Gabapentin Enacarbil Sales by Application (2017-2028)
10.2.2 Middle East and Africa Gabapentin Enacarbil Revenue by Application (2017-2028)
10.3 Middle East and Africa Gabapentin Enacarbil Market Size by Country
10.3.1 Middle East and Africa Gabapentin Enacarbil Sales by Country (2017-2028)
10.3.2 Middle East and Africa Gabapentin Enacarbil Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Arbor Pharma
11.1.1 Arbor Pharma Corporation Information
11.1.2 Arbor Pharma Overview
11.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Arbor Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Arbor Pharma Recent Developments
11.2 Astellas
11.2.1 Astellas Corporation Information
11.2.2 Astellas Overview
11.2.3 Astellas Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Astellas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Astellas Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GlaxoSmithKline Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 Glenmark Pharma
11.4.1 Glenmark Pharma Corporation Information
11.4.2 Glenmark Pharma Overview
11.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Glenmark Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Glenmark Pharma Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Depomed
11.6.1 Depomed Corporation Information
11.6.2 Depomed Overview
11.6.3 Depomed Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Depomed Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Depomed Recent Developments
11.7 Teva
11.7.1 Teva Corporation Information
11.7.2 Teva Overview
11.7.3 Teva Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Teva Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Teva Recent Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Overview
11.8.3 Mylan Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mylan Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Overview
11.9.3 Novartis Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novartis Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis Recent Developments
11.10 Apotex
11.10.1 Apotex Corporation Information
11.10.2 Apotex Overview
11.10.3 Apotex Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Apotex Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Apotex Recent Developments
11.11 Sun Pharmaceutical
11.11.1 Sun Pharmaceutical Corporation Information
11.11.2 Sun Pharmaceutical Overview
11.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sun Pharmaceutical Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sun Pharmaceutical Recent Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Corporation Information
11.12.2 Aurobindo Pharma Overview
11.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Aurobindo Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aurobindo Pharma Recent Developments
11.13 Intas
11.13.1 Intas Corporation Information
11.13.2 Intas Overview
11.13.3 Intas Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Intas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Intas Recent Developments
11.14 Amneal
11.14.1 Amneal Corporation Information
11.14.2 Amneal Overview
11.14.3 Amneal Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Amneal Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Amneal Recent Developments
11.15 Marksans Pharma
11.15.1 Marksans Pharma Corporation Information
11.15.2 Marksans Pharma Overview
11.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Marksans Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Marksans Pharma Recent Developments
11.16 Alkem
11.16.1 Alkem Corporation Information
11.16.2 Alkem Overview
11.16.3 Alkem Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Alkem Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Alkem Recent Developments
11.17 Jiangsu Enhua
11.17.1 Jiangsu Enhua Corporation Information
11.17.2 Jiangsu Enhua Overview
11.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Jiangsu Enhua Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Jiangsu Enhua Recent Developments
11.18 Jiangsu Hengrui
11.18.1 Jiangsu Hengrui Corporation Information
11.18.2 Jiangsu Hengrui Overview
11.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Jiangsu Hengrui Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Jiangsu Hengrui Recent Developments
11.19 Sailike Pharma
11.19.1 Sailike Pharma Corporation Information
11.19.2 Sailike Pharma Overview
11.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Sailike Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Sailike Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gabapentin Enacarbil Industry Chain Analysis
12.2 Gabapentin Enacarbil Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gabapentin Enacarbil Production Mode & Process
12.4 Gabapentin Enacarbil Sales and Marketing
12.4.1 Gabapentin Enacarbil Sales Channels
12.4.2 Gabapentin Enacarbil Distributors
12.5 Gabapentin Enacarbil Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gabapentin Enacarbil Industry Trends
13.2 Gabapentin Enacarbil Market Drivers
13.3 Gabapentin Enacarbil Market Challenges
13.4 Gabapentin Enacarbil Market Restraints
14 Key Findings in The Global Gabapentin Enacarbil Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer